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Abstract  
Systemic pseudohypoaldosteronism type-1 (PHA-1) is a severe salt-losing syndrome 
caused by loss-of-function mutations of ENaC characterized by neonatal life-threatening 
hypovolemia and hyperkalemia. Plasma aldosterone reaches very high plasma levels 
under hypovolemic and hyperkalemic challenge, that could respectively lead to either 
increased or decreased sodium reabsorption via the Na+/Cl- co-transporter NCC. We 
generated adult inducible nephron-specific αENaC knockout mice (Scnn1aPax8/LC1) that 
exhibit hyperkalemia and body weight loss when kept under regular salt diet mimicking 
PHA-1. Despite high plasma aldosterone levels, NCC protein expression and 
phosphorylation are downregulated, indicating that NCC is aldosterone-insensitive under 
hyperkalemia. However, although plasma aldosterone level remains significantly 
increased, NCC expression is restored to control levels following high sodium and 
reduced potassium diet (rescue diet), and body weight, plasma and urinary electrolyte 
concentrations and excretion are mostly normalized. Finally, shift to regular diet after 
rescue diet reinstates severe PHA-1 syndrome accompanied by significantly reduced 
NCC phosphorylation. In conclusion, lack of ENaC-mediated sodium transport along the 
nephron cannot be compensated by other sodium channels and/or transporters, but solely 
by high sodium and reduced potassium diet. We conclude that hyperkalemia becomes 
the determining factor to downregulate NCC activity regardless of sodium loss in the 
ENaC-mediated salt-losing PHA-1 phenotype.  
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Introduction 
In case of decrease in volume of blood plasma, the mineralocorticoid hormone 
aldosterone mediates at least in part Na+ retention by activating the Renin-Angiotensin-
Aldosterone System (RAAS) and thus salt transport in the distal nephron. In this condition 
K+ secretion remains unchanged. Aldosterone is also released if plasma K+ is increased, 
allowing K+ secretion in the distal nephron without affecting Na+ reabsorption. This 
mechanism is commonly referred as the “aldosterone paradox” but how aldosterone 
exerts these apparently opposite effects is not yet completely understood 1. Na+ 
reabsorption in the distal nephron occurs through two different means: the electroneutral 
thiazide-sensitive Na+/Cl- co-transporter (NCC) expressed mainly in the DCT1 with lower 
expression in the DCT2, and the amiloride-sensitive epithelial Na+ channel (ENaC) 
expressed in the aldosterone sensitive distal nephron (ASDN) namely the DCT2, CNT 
and CD. Na+ and K+ are the most important cations for the transmembrane potential 
across the plasma membrane, and electrogenic Na+ reabsorption through ENaC 
increases the driving force for K+ transport and thus K+ excretion. ENaC consists of three 
different subunits α, β and γ organized in a heteromultimeric complex. The role of ENaC 
in humans was demonstrated by mutations in the channel causing Mendelian forms of 
hypertension and hypotension, namely Liddle´s syndrome and pseudohypoaldosteronism 
type 1 (PHA-1), respectively 2, 3. PHA-1 is a salt-losing syndrome accompanied by 
hyperkalemia and metabolic acidosis. Systemic PHA-1 is an autosomal recessive form 
characterized by a severe neonatal salt-losing syndrome accompanied by (often lethal) 
hyperkalemia and metabolic acidosis. The majority of the pathogenic mutations map to 
αENaC predicting near-complete truncations of the protein.  
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To define the physiological role of ENaC in vivo, a mouse model with constitutive 
inactivation of the α subunit of ENaC has been generated which leads to death soon after 
birth. αENaC knockout mice display lung fluid clearance failure, hyperkalemia and sodium 
loss 4. The constitutive lack of β and γENaC subunits in mice leads to a milder pulmonary 
phenotype, but the kidney phenotype characterized by hyperkalemia and metabolic 
acidosis is predominant, and accompanied by elevated plasma aldosterone levels. The β 
and γENaC knockouts also die within 48h hours after birth 5, 6. α, β and γ ENaC knockouts 
thus present with renal phenotypes similar to that of humans with PHA type 1, but did not 
allow analysing the consequence of ENaC deletion specifically in the kidney and/or during 
adulthood 4-6. To further dissect the role of ENaC along the nephron, we previously 
reported that mice with αENaC inactivated in the CD are able to maintain sodium and 
potassium balance 7. This suggested that the late DCT and/or the CNT are rather involved. 
More recently, we studied the phenotype of renal CNT/CD-specific αENaC knockout mice. 
Only under low salt diet these mice develop a mild PHA-1 with higher urinary sodium 
excretion accompanied by a higher urinary volume and a lower osmolarity. Under sodium-
deficient diet, a significant lower body weight, a higher urinary sodium excretion and 
hyperkalemia were observed 8. These data thus demonstrate that αENaC deletion in the 
CNT is sufficient to induce clinical symptoms of PHA-1 suggesting that the CNT plays a 
critical role in achieving sodium and potassium balance. The model, however, does not 
recapitulate the severe often lethal phenotype observed in newborns suffering from PHA-
1 with deletion or truncation mutations in the αENaC gene locus 9, 10. 
The aim of the present work was to develop an inducible renal tubule-specific αENaC 
knockout in adulthood to determine whether ENaC-deficiency along the nephron mimics 
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the severe PHA-1 phenotype. Our data clearly demonstrate that (i) αENaC expression is 
indispensable in adult kidney for sodium and potassium regulation, and the mice develop 
a severe pseudohypoaldosteronism that mimics the human PHA-1, (ii) the knockout mice 
can be rescued with high sodium and reduced potassium diet allowing restoration of 
normal sodium and potassium excretion, (iii) a down-regulation of NCC expression and 
phosphorylation occurs when knockout animals are subjected to a normal salt diet. The 
increased sodium delivery to the CNT/CCD may be an attempt to prevent death caused 
by hyperkalaemia. 
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Results 
Generation of inducible nephron-specific Scnn1aPax;LC1 knockout mice  
To induce the deletion of the αENaC (Scnn1a) gene locus in adulthood, we treated 1-
month-old Scnn1aPax8/LC1 triple transgenic animals (carrying the Scnn1alox/lox, Pax8-rtTA 
and LC1 transgenes, respectively) and their control littermates (Scnn1alox/lox;Pax8-rtTA 
and Scnn1alox/lox;LC1, namely Scnn1aPax8 and Scnn1aLC1) with doxycycline. We assessed 
the presence of the deleted Scnn1a allele (Δ) by PCR on genomic DNA extracted from 
kidney, lung, and liver, and identified the Scnn1a Δ allele in kidney and in liver of 
Scnn1aPax8/LC1 mice but not in lung or in Scnn1aPax8, Scnn1aLC1 and Scnn1alox/lox controls 
(Supplementary Fig.1A). Analysis of Scnn1a mRNA transcript expression in kidney by 
real-time PCR demonstrated a significant reduction to 20% of controls in the 
Scnn1aPax8/LC1 knockout mice, whereas the expression of βENaC (Scnn1b) and γENaC 
(Scnn1g) was not affected (Fig.4A). Immunofluorescence on kidneys from animals under 
standard salt diet revealed efficient recombination of the Scnn1a gene locus. In overviews 
on the renal cortex, control mice showed numerous αENaC-positive renal tubules, while 
Scnn1aPax8/LC1 knockout mice revealed only a few remaining αENaC-positive renal 
tubules. In contrast, γENaC was similarly detectable in control and Scnn1aPax8/LC1 
knockout mice (Supplementary Fig.1B). High magnifications revealed that αENaC was 
efficiently deleted in all distal tubule cells that express the Cre protein. Only a few single 
cells in the ASDN did not express Cre and continued to express αENaC (Supplementary 
Fig.1C). Although the recombination of the Scnn1a allele (Δ) occurs also in liver 
(Supplementary Fig.1A), αENaC mRNA and protein expression levels in this organ did 
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not differ between control and Scnn1aPax8/LC1 knockout mice (Supplementary Fig.2A and 
B). 
αENaC expression is crucial to maintain sodium and potassium homeostasis in 
adulthood 
One-month-old Scnn1aPax8/LC1 knockout and control animals were fed with a regular salt 
diet and placed in metabolic cages for four consecutive days to determine their urinary 
and plasma Na+ and K+ concentrations (Supplementary Fig. 3A). Following doxycycline 
treatment control animals kept gaining weight in their growing phase, whereas 
Scnn1aPax8/LC1 knockout mice rapidly lost body weight and manifested severe sickness 
(Fig. 1A and Supplementary Fig. 4). All knockout animals analysed lost more than 10% 
of their initial body weight and were thus sacrificed. Moreover, Scnn1aPax8/LC1 knockout 
mice presented with signs of hyponatremia, and developed a severe hyperkalemia (Fig. 
1B). Creatinine levels did not vary in urine, but were significantly increased in plasma of 
Scnn1aPax8/LC1 knockout mice (Supplementary Fig. 5A and B). Creatinine clearance was 
not significantly different among the two groups, despite an almost 50% reduction in 
knockouts (Supplementary Fig. 5C). During this period, we observed no difference in 
water intake or urine output compared to water intake with the exception of a decrease in 
food intake and in amount of feces at the fourth day following doxycycline induction in 
knockout mice (Supplementary Fig. 6A-D). This was accompanied by significantly 
increased cumulative 24h-urinary sodium and a decreased 24h-urinary potassium 
excretion (Fig. 1C and D). Finally, a significant increase in plasma aldosterone levels 
(controls: 3±1 nM, n=8 versus knockouts: 32±5 nM, n=7; P≤0.001) was detected in the 
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kidney-specific knockout mice mimicking a severe pseudohypoaldosteronism type 1 
phenotype. 
High Na+ and reduced K+ diet restores body weight gain and electrolyte balance in 
Scnn1aPax8/LC1 knockout mice  
The animals were induced by doxycycline during three days under a standard salt diet. At 
the third day of the doxycycline treatment, the diet was changed to high Na+ and reduced 
K+ during two months to compensate for Na+ loss and reduced K+ excretion, and animals 
were analysed during the last three days of high Na+ and reduced K+ treatment 
(Supplementary Fig. 3B). Nephron-specific Scnn1aPax8/LC1 knockout mice displayed 
body weight gain as control animals, and presented with normal natremia and kalemia, 
although plasma K+ of knockouts remained significantly higher than that of controls (Fig. 
2A and B and Supplementary Fig. 4). The cumulative urinary sodium and potassium 
balance in Scnn1aPax8/LC1 knockout mice was re-established in comparison with the 
controls (Fig. 2C and D), and food and water intake, feces amount, urine volume 
compared to water intake became indistinguishable between the two groups 
(Supplementary Fig. 7A-D). These data indicate that the salt-losing phenotype of 
Scnn1aPax8/LC1 knockout mice can be restored by compensating sodium and potassium 
intake, and nearly 80% of the initial Scnn1aPax8/LC1 knockout mice survived (28 out of 36). 
Interestingly, plasma aldosterone levels were 45-fold higher compared to controls 
(0.2±0.03 nM, n=14 in controls and 10±2 nM, n=13 in knockouts, P<0.001).  
The return to a standard diet reinstates a severe type 1 PHA characterized by 
metabolic acidosis 
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When we returned to the standard diet following two months of high Na+ and reduced K+ 
treatment (Supplementary Fig. 3C), Scnn1aPax8/LC1 knockout mice rapidly lost body 
weight (Fig. 3A and Supplementary Fig. 4), and presented with significantly lower 
plasma sodium, but normalized cumulative sodium excretion (Fig. 3B and C) most likely 
because of reduced food intake and thus reduced Na+ input (Supplementary Fig. 8A and 
D) and hyperkalemia accompanied by reduced cumulative potassium excretion (Fig. 3B 
and D). With exception of water intake and urine volume to water intake ratio 
(Supplementary Fig. 8B and C), Scnn1aPax8/LC1 knockout animals significantly reduced 
food intake with consequences on feces output (Supplementary Fig. 8A and D). 
Aldosterone levels stayed significantly increased in knockouts (6±2 nM, n=8 in controls 
and 53±8 nM, n=6 in knockouts, P<0.01). While plasma Ca2+ and Cl- levels were 
comparable between the two groups, blood pH was significantly reduced in knockout mice 
(Table 1). To get insights into acidosis, we analysed pCO2, cBase(Ecf) and cHCO3- in 
blood. While pCO2 did not change, we found a significant decrease in the levels of 
cBase(Ecf) and cHCO3- in Scnn1aPax8/LC1 knockout mice, revealing the inability of these 
animals to excrete acid via the kidney (Table 1). 
Downregulation of NCC phosphorylation despite severe salt-losing syndrome 
To analyse whether the expression of β and γENaC subunits changes when αENaC is 
absent, we analysed β and γ mRNA and protein levels under standard diet, under rescue 
diet (high sodium and reduced potassium) and back to standard diet after rescue diet 
(Supplementary Fig. 3A-C). β and γENaC mRNA expression was not modified in all 
three diets (Fig. 4A-C). At the protein level, we observed that γENaC expression did not 
change, but βENaC levels were increased under standard salt diets (Fig. 4D-F) 
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suggesting an attempt to compensate for αENaC absence. The sodium-chloride co-
transporter, also known as thiazide-sensitive sodium-chloride co-transporter NCC 
reabsorbs sodium and chloride ions from the tubular fluids in distal convoluted tubules of 
the nephron, and plays a major role in Na+ balance 11. To verify whether absence of 
αENaC in adult kidney might have any effect on NCC regulation, we analysed NCC mRNA 
transcript and protein expression following induction of αENaC-deficiency under the three 
different diet phases. Total mRNA and protein NCC levels were decreased under standard 
salt diet before the rescue phase, and surprisingly did not vary when back to standard diet 
after the high Na+ and reduced K+ treatment (Fig. 4A-C, and Fig. 5A-C). Despite the 
establishment of a severe PHA-1 phenotype under the standard diets, Scnn1aPax8/LC1 
knockout mice presented with a significantly decreased NCC T53 and T58 
phosphorylation (Fig. 5A-C). In contrast, high Na+ and reduced K+ restored the 
phosphorylated state of NCC to control levels (Fig. 5B). Altogether these data indicate 
that the absence of αENaC in the nephron leads to decreased NCC activity, and that a 
diet rich in Na+ and reduced in K+ is sufficient to restore electrolyte balance and NCC 
phosphorylation. 
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Discussion 
Deletion of αENaC/Scnn1a along the nephron leads to a severe PHA-1 phenotype 
Scnn1aPax8/LC1 knockout mice develop a severe pseudohypoaldosteronism syndrome with 
rapid weight loss, disturbance of plasma Na+/K+ concentrations, significantly increased 
urinary Na+ loss and decreased K+ excretion presenting all clinical features of the human 
PHA-1. The adult phenotype mimics as well that of the newborns with constitutive deletion 
of the αENaC (Scnn1a), βENaC (Scnn1b) and γENaC (Scnn1g) subunits 4-6 (Fig. 1) and 
confirms the critical role of ENaC function within the ASDN. Although we could not asses 
it directly because the animals are too small and sick to be measured, the Scnn1aPax8/LC1 
knockouts are most likely in a severe hypovolemic state that, together with reduced food 
intake, could explain body weight loss. The phenotype observed in Scnn1aPax8/LC1 
knockout mice is more severe than the one with CNT/CD-specific ENaC inactivation 8 and 
closely reproduces the pharmacological inactivation of ENaC by acute administration of 
amiloride in one-week salt-depleted rats 12. Pax8 expression has been described in liver, 
and we observed partial DNA recombination at the Scnn1a gene locus also in this organ 
(Supplementary Fig. 1A). However, αENaC mRNA and protein levels in liver did not 
change between control and knockout animals (Supplementary Fig. 2A and B) and no 
relevant ENaC function has been described so far in liver that is linked to sodium and 
potassium homeostasis. Whole heterozygous mutant αENaC knockout mice maintain 
blood pressure and sodium balance even upon different sodium diets 13. Moreover, no 
DNA recombination at the αENaC (Scnn1a) gene locus was observed in lung 
(Supplementary Fig. 1A) where ENaC function in alveolar fluid clearance is well known 
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14. The results presented in this article clearly demonstrate that ENaC deficiency along 
the nephron cannot be compensated by other sodium-absorbing channels. 
Rescue of sodium and potassium homeostasis in Scnn1aPax8/LC1 mice by high 
sodium and reduced potassium diet  
The constitutive mineralocorticoid receptor knockout mice that show impaired ENaC 
activity resembling inborn PHA-1 when untreated, can be rescued by NaCl addition to the 
diet, however retaining sodium-losing defects 15. We thus asked whether Scnn1aPax8/LC1 
knockout mice could compensate sodium loss and hyperkalemia with a high Na+ and 
reduced K+ diet. Indeed, a diet rich in Na+ and reduced in K+ is sufficient to almost 
completely restore body weight and plasma and urinary electrolytes in Scnn1aPax8/LC1 
knockout mice (Fig. 2, Supplementary Fig. 4 and 7) and it would be interesting to explore 
whether high salt alone (with normal potassium) can correct the hyperkalaemia. The 
localization of the mineralocorticoid receptor in the ASDN, and in other renal cell types 16 
and/or a largely aldosterone-independent ENaC function in the DCT2/CNT 17 may 
contribute to the complexity of corticosteroid effects on ASDN function. A crosstalk 
between the angiotensin II membrane receptor and the mineralocorticoid receptor 
signalling pathways is well established, as demonstrated by Shibata et al. and Terker et 
al. 18, 19. Conditional inactivation of the mineralocorticoid receptor in the CD and late CNT 
is only compensated under standard diet, but no longer when sodium supply is limited 20. 
The phenotype is thus comparable to that of late CNT/CD-specific ENaC knockout where 
the same AQP2-Cre transgenic line was used 7. Again, the relatively mild phenotype in 
the CNT/CD ENaC knockout mice can be explained by a compensation of renal ENaC 
activity via the RAAS system in more proximal ENaC-containing nephron segments, like 
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the “early” CNT and “late” DCT. This may point to a crucial mineralocorticoid receptor 
function in more proximal nephron segments, like the DCT1, CTAL, OMTAL independent 
from regular ENaC activity. Interestingly, the return to the standard diet after two months 
of high Na+ and reduced K+ treatment reinstates a PHA type 1 phenotype. Despite sodium 
loss, sodium may be delivered to more distal nephron segments to favour potassium 
excretion (Fig. 3 and Supplementary Fig. 4 and 8). We have recently demonstrated that 
activation of the RAAS system in the kidney can compensate for the absence of αENaC 
in colon in a mouse model of αENaC deletion in intestinal superficial cells 21. Thus the 
intestine of the Scnn1aPax8/LC1 knockout mice may play a compensatory role with the 
attempt to prevent Na+ loss and K+ retention. When αENaC is deleted along the nephron, 
β and γENaC subunits cannot form fully functional channels 22. By contrast, when β or 
γENaC is deleted, the remaining αγ or αβ channels may induce sufficient activity to 
maintain sodium balance. Indeed Knepper and coworkers have shown in vivo that the 
protein abundance of the αENaC subunit was regulated by salt diet and aldosterone, while 
the γENaC was cleaved in response to aldosterone and dietary Na+ 23, 24. In this study we 
observed no difference in the cleaved γENaC subunit in both wild-type and knockout 
animals under the different diets.  
Aldosterone-independent regulation of NCC in Scnn1aPax8/LC1 mice 
Described as an “aldosterone paradox”, aldosterone can trigger differential regulation of 
Na+ and K+ transport between DCT1 and the ASDN 1. Following induction of ENaC 
deletion along the nephron, NCC is significantly less phosphorylated. This finding is 
unexpected, as the Scnn1aPax8/LC1 mice suffer from hyponatremia and hyperkalemia (Fig. 
1) accompanied by high plasma aldosterone levels. The hyperkalemia may trigger the 
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apparent contradictory aldosterone-induced NCC down-regulation. Indeed, a high-K+ diet 
decreases NCC 25, 26. The K+-loading-induced NCC down-regulation may occur rapidly in 
response to both an oral potassium intake and an intravenous potassium infusion 27, 28 is 
aldosterone-independent 29 and was shown to overrule hypovolemic NCC stimulation 30. 
The NCC downregulation may thus improve renal K+ excretion.  
This novel animal model points to the DCT2/CNT as crucial aldosterone-sensitive nephron 
segment. However, we do not exclude that the CD may still play an important role under 
challenging conditions, even if ENaC-deletion per se in this segment does not seem to be 
a prerequisite for sodium and potassium balance 7. Indeed, two recent studies unveil an 
ENaC regulation largely independent from aldosterone 17 and likely dependent on 
vasopressin 31 suggesting that sodium, but also potassium handling might be regulated in 
a cell-type and nephron segment-specific manner. In conclusion, Scnn1aPax8/LC1 knockout 
mice fully reproduce the PHA-1 phenotype, and hyperkalemia remains the predominant 
and life-threatening feature to be avoided even at the expense of increased sodium loss.  
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Concise methods 
Generation of inducible nephron-specific αENaC-deficient mice. 
To inactivate the Scnn1a gene in all proximal and distal tubules, and the entire collecting 
duct system of the kidney, we took advantage of Tet-On and Cre-loxP systems. Nephron-
specific αENaC-deficient mice (Scnn1alox/lox;Pax8-rtTAtg/0;TRE-LC1tg/0) and littermate 
controls (Scnn1alox/lox;Pax8-rtTAtg/0, Scnn1alox/lox;TRE-LC1tg/0, and Scnn1alox/lox) were 
obtained by interbreeding Scnn1alox/lox;Pax8-rtTAtg/0 with Scnn1alox/lox;TRE-LC1tg/0 mice. 
Genotyping of the mice was performed by PCR analysis of ear biopsies 32 at the age of 
weaning using the following primers: Pax8-rtTA ST1: 5’-CCATGTCTAGACTGGACAAGA-
3’, Pax8-rtTA ST2: 5’-CTCCAGGCCACATATGATTAG-3’; LC-1 Cre3: 5′-
TCGCTGCATTACCGGTCGATGC-3′; LC-1 Cre4: 5′-
CCATGAGTGAACGAACCTGGTCG-3′. Animals were housed in a temperature- and 
humidity-controlled room with an automatic 12-hour light/dark cycle and had free access 
to food and tap water. Experimental procedures and animal maintenance followed federal 
guidelines and were approved by local authorities, and adhered to the NIH Guide for the 
Care and Use of Laboratory Animals (http://grants.nih.gov/olaw/references/phsol.htm). 
Induction of nephron-specific αENaC-deficient mice. 
We generated inducible renal tubule-specific αENaC knockout mice using the αENaC 
floxed allele (Scnn1alox/lox 32), the Pax8-rtTAtg/0 transgenic mice expressing the reverse 
tetracycline transactivator under control of the Pax8 promoter that is driving the 
expression in all proximal and distal tubular cells along the nephron 33, and the TRE-
LC1tg/0 transgenic mice where the expression of the Cre recombinase and luciferase is 
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under the control of the tetracycline response element (TRE) 34. In the presence of 
doxycycline the reverse tetracycline transactivator binds and activates the tetracycline-
responsive element, thereby triggering Cre recombinase expression. To induce the 
deletion of the Scnn1a gene, 4-week-old Scnn1alox/lox;Pax8-rtTA;LC1 mice and control 
littermates were treated with 2 mg/mL doxycycline and  2% sucrose in the drinking water, 
following 2 days of 2% sucrose in the drinking water. The doxycycline hydrochloride 
(Sigma, Deisenhofen, Germany) was protected from light, and prepared fresh every two 
days. The recombination of the floxed Scnn1a alleles in kidney, lung and liver was 
investigated by DNA-based PCR analysis (using the primers described above) and at the 
mRNA level using TaqMan PCR (Applied Biosystems 7500).  
Quantitative RT-PCR 
Organs were homogenized using Tissue Lyzer (QIAGEN) and RNA was extracted with 
the guanidinium thiocyanate-phenol-chloroform extraction method (QIAzol lysis reagent, 
QIAGEN). 1.5 μg of RNA were reverse transcribed using the PrimeScript™ RT reagent 
Kit with gDNA Eraser (Takara). Quantitative RT-PCR was performed by TaqMan PCR 
using Applied Biosystems 7500. Each measurement was taken in duplicate. 
Quantification of fluorescence was normalized to β-actin. Primer sequences were 
published previously 35. 
Salt diets and metabolic cages 
The diets were given as solid food (pellet, standard cages) or as powder (metabolic 
cages). After 3 days of doxycycline treatment under standard salt diet (0.17% sodium and 
0.97% potassium given as powder, ssniff Spezialdiäten GmbH) mice were fed for 3 days 
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with a diet rich in sodium and low in potassium (3.5% sodium, potassium < 0.1% given as 
powder, ssniff Spezialdiäten GmbH), that was supplemented with 0.2% potassium in 
drinking water during the following 2 months. At the end of this period, mice were fed 
again with a normal salt diet for 3 days (0.17% sodium and 0.97% potassium given as 
powder, ssniff Spezialdiäten GmbH). For the metabolic cage studies, experimental mice 
and controls from the same litter were placed in individual metabolic cages (Tecniplast, 
Buguggiate, Italy) and fed with the different salt diets. The high concentration of plasma 
aldosterone in control animals on the standard salt diet may reflect the choice of a control 
diet relatively lower in Na+ and higher in K+ content than other standard rodent chows. 
During the experiments the animals had free access to food and water. Body weight, food 
and water intake, urine excretion and quantity of feces were monitored once-daily at the 
same time. At the end of the experiments, blood was collected, mice were sacrificed (by 
decapitation), and kidney, lung and liver were collected for molecular analyses.  
Urine and Serum/Plasma Analysis 
Urine and serum/plasma osmolarity as well as sodium, potassium, and bicarbonate 
concentrations were analysed by using a flame photometer (Cole-Parmer). Plasma 
aldosterone levels were measured according to standard procedures using a RIA (Coat-
A-Count RIA kit; Siemens Medical Solutions Diagnostics, Ballerup, Denmark). Mouse 
samples with values >1200 pg/ml were further diluted using a serum pool with a low 
aldosterone concentration (<50 pg/ml). The urinary and plasmatic creatinine 
concentrations were measured by enzyme-linked immunosorbent assay (ELISA) at the 
Zurich Integrative Rodent Physiology (ZIRP) platform.  
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Blood gas analyzes  
The mice were anesthetized with 3% isoflurane and 97% atmospheric air mixture. The 
thorax was opened and the heart was exposed. 150-300 µl of blood was withdrawn from 
the right atrium with a heparin coated syringe (Pico50, Radiometer, Denmark). The blood 
was immediately measured by a blood gas analyzer (ABL800 Flex, Radiometer, 
Denmark). 
Western blot analyzes 
Frozen tissues were homogenized and protein extracted as described 36. Anti-α, β, 
γENaC, NCC and pT53-NCC and pT58-NCC antibodies were obtained and used as 
described 27. Phospho-antibodies were diluted 1/1000. Anti-β-actin antibody (Sigma-
Aldrich) was used as loading control.  
Immunofluorescence on kidney sections 
Kidneys were fixed by vascular perfusion and processed for immunohistochemistry as 
previously described 37. Serial cryosections (5 μm) were incubated overnight at 4°C with 
polyclonal rabbit antisera against either Cre (dilution 1:10’000) 38, α-ENaC (dilution 
1:1’000) 27 , or γ-ENaC (dilution 1:20’000) 39. The primary antibodies were revealed with 
a Cy3-conjugated donkey anti-rabbit IgG (Jackson Immuno Research Labs, West Grove, 
PA) diluted 1:1’000. Moreover, some sections were incubated also with FITC-conjugated 
goat anti-mouse IgG (Jackson Immuno Research Laboratories) diluted 1:100. Images 
were acquired with a Leica DFC 350 FX charge-coupled device camera (Leica, 
Heerbrugg, Switzerland) and processed by Leica Application Suite software before 
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importing into Adobe Photoshop CS3 and Powerpoint for image arrangement and 
labeling. The primary antibodies were omitted in control experiments.  
Statistical analysis 
Results are presented as mean ± SEM. Data between control and Scnn1alox/lox;Pax8-
rTta;LC1 mice were analysed by unpaired t test. P values <0.05 were considered 
statistically significant. 
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Figure legends 
 
Figure 1 Inducible Scnn1a knockout mice develop a PHA type 1 phenotype under 
regular diet.  
(A) Body weight changes (Δ body weight) in percentage of initial body weight monitored 
during four consecutive days following doxycycline administration at day 0. A total of 19 
control (straight line) and 20 Scnn1a knockout mice (Scnn1aPax8/LC1, dashed line) were 
analyzed. (B) Plasma Na+ and K+ measurements (mmol) in control (n=14) and knockout 
mice (n=11). (C) 24h- cumulative urinary sodium and (D) potassium excretion (mmol) of 
control (n=11) and knockout mice (n=10). Results are presented as mean ± SEM and 
data were analysed by unpaired t test. P values <0.05 were considered statistically 
significant. 
 
Figure 2 High Na+ and reduced K+ diet normalizes body weight loss and plasma 
and urinary electrolyte concentration.   
(A) Body weight changes (Δ body weight) in percentage of initial body weight in control 
(n=11) and knockout mice (n=11) at the end of two months of high Na+ and reduced K+ 
diet (rescue diet). (B) Plasma Na+ and K+ concentrations in control (n=6) and knockout 
mice (n=4). (C) 24h-urinary cumulative sodium and (D) potassium excretion (mmol) of 
control (n=11) and knockout mice (n=11). -3, -2, -1 and 0 correspond to the last days of 
the rescue diet. Results are presented as mean ± SEM and data were analysed by 
unpaired t test. P values <0.05 were considered statistically significant. 
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Figure 3 The switch to standard diet reinstates a severe PHA type 1 phenotype. 
(A) Body weight changes (Δ body weight) in percentage of initial body weight in control 
(n=8) and Scnn1aPax8/LC1 knockout mice (n=8) during three days of standard diet after 
two months of high Na+ and reduced K+ diet. (B) Plasma Na+ and K+ concentrations in 
control (n=15) and knockout mice (n=13). (C) 24h-urinary sodium excretion of control 
and knockout mice during three days of standard diet (+1, +2, +3) after two months of 
high Na+ and reduced K+ diet. (D) 24h-urinary potassium excretion of control and 
knockout mice. n= 8 mice per genotype. Results are presented as mean ± SEM and 
data were analysed by unpaired t test. P values <0.05 were considered statistically 
significant. 
 
Figure 4 βENaC protein expression increases in absence of αENaC. 
α, β, γENaC and NCC mRNA transcript expression in the kidney determined by 
quantitative real-time PCR and normalized to β-actin in control (white) and knockout 
(black column) mice (A) under standard diet, (B) following rescue (high sodium and 
reduced potassium) diet and (C) three days following the return to the standard diet, n≥4 
per genotype. (D) Representative Western blot analyses for α, β and γENaC on the 
whole kidney of control and Scnn1aPax8/LC1 knockout mice under standard diet (n=4 per 
genotype), (E) following a high Na+/reduced K+ (rescue) diet (controls: n=7; knockouts 
n=7), and (F) three days following the switch to the standard diet (controls: n=13; 
knockouts n=13). Protein expression was normalized to the amount of β-actin and 
reported relative to control values. Results are presented as mean ± SEM and data were 
analysed by unpaired t test. P values <0.05 were considered statistically significant. 
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Figure 5 NCC phosphorylation is normalized following rescue diet.  
(A) Representative Western blot analyses for total NCC and phosphorylated pT53- and 
pT58-NCC on the whole kidney of control (n=14) and Scnn1aPax8/LC1 knockout mice 
(n=14) under standard diet, (B) following a high Na+/reduced K+ (rescue) diet (controls: 
n=12; knockouts n=11), and (C) three days following the switch to the standard diet 
(controls: n=6; knockouts n=8). Protein expression was normalized to the amount of β-
actin and reported relative to control values. Results are presented as mean ± SEM and 
data were analysed by unpaired t test. P values <0.05 were considered statistically 
significant. 
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Table 1 
Blood parameters of mice after the return to the standard salt diet following two months 
of rescue diet. 
 Control (n=7) 
Experimental group 
(n=6) 
Na+ (mmol.l-1) 145±0,4 137±1,3 *** 
K+ (mmol.l-1) 5±0,2 8±0,5 *** 
Ca2+ (mmol.l-1) 1,3±0,01 1,2±0,01 
Cl- (mmol.l-1) 113±0,9 111±1,2 
pH 7±0,02 7±0,02 * 
pCO2 (mmHg) 41±1,9 40±2,5 
cBase (Ecf) -4±0,8 -8±0,9 *** 
cHCO3- (aP,st) 19±0,6 16±0,5 *** 
Data are average ± SEM. * P <0.05; *** P <0.001. cBase (Ecf): standard base excess. 
cHCO3- (aP,st): standard bicarbonate. 
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